Cancer Insights

Clear filters
Micrograph of malignant melanoma (copyright 2010, Nephron)
Micrograph of malignant melanoma (copyright 2010, Nephron)

What Determines Whether a Melanoma Patient Will Respond to Checkpoint Blockade Drugs?

In-Depth Insights |  Written by Emma Shtivelman, PhD

Of all cancer types, melanoma is the most investigated in terms of its potential to be treated through immune system-based approaches. More ...

Learn More
CAR T-cell therapy (Caron A. Jacobson and Jerome Ritz)

The CAR T-Cell Treatment: Will It Work for Solid Tumors?

In-Depth Insights |  Written by Emma Shtivelman, PhD

Chimeric antigen receptor (CAR) T-cell therapy is a new, immune system-based cancer treatment that has garnered recent media attention. In ...

Learn More
High magnification micrograph of a gastric neuroendocrine tumor.
High magnification micrograph of a gastric neuroendocrine tumor. (Copyright © 2011 Nephron)

Hormone-Mimicking Drugs Are Used To Treat Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

In-Depth Insights |  Written by Emma Shtivelman, PhD

Neuroendocrine tumors (NETs) can arise wherever neuroendocrine (hormone-producing) cells are found—which is in most organs. Most NETs ...

Learn More